2020 National Health Research Forum

For more than 30 years, the organizations that constitute the Research!America alliance – patient advocates, research universities, independent research institutes, academic health centers, scientific societies, biomedical, medical technology and data companies, philanthropies, and more – have fought hard and successfully for life-saving progress. During a year in which alliance members were called to defeat COVID-19, even as you confronted its destructive effects, our alliance members – you – stepped up. While Research!America advocacy and communications efforts redoubled in 2020 (40 letters and 7,000 emails to Congress; 141 meetings with congressional offices; and a more than five-fold...
Dear Research Advocate, How to Fight for the Future : Ruth Bader Ginsburg lived her life fearlessly. She refused to let the present dictate the future. Her dogged persistence in the face of seemingly insurmountable obstacles and her sense of civic responsibility transcended ideology. Regardless of the chain of events her death triggered, our nation would be well served by channeling Justice Ginsburg’s fierce commitment to societal progress as we confront a confluence of daunting national and global challenges. So what can research advocates do? The following thoughts are suggestive, not exhaustive! Make the Case : The American Academy of Arts and Sciences will release a report next week, “...
Dear Research Advocate, If you weren’t able to join us for the National Health Research Forum, you can watch the recordings from the Forum platform . The popular short videos from federal officials, members of Congress, and leaders from across the research and public health ecosystem are posted on our YouTube channel , where all the recordings will soon appear. CNN, C-SPAN, and PBS (among other media outlets) covered several sessions; watch them here now: Secretary of HHS Alex M. Azar, II interviewed by Susan Dentzer Anthony Fauci, MD interviewed by Judy Woodruff ADM Brett Giroir, MD , interviewed by Sanjay Gupta, MD Robert Redfield, MD interviewed by Frank Sesno Vaccine Development: Are we...
Dear Research Advocate, Wow, what a day! I hope you were among the many who joined us yesterday for the first day of Research!America’s 2020 Virtual National Health Research Forum — Straight Talk: Securing a Science-Strong Future. Here’s some of what we learned: We must "communicate, communicate, communicate — but in one voice. Leadership at all levels need to display unwavering enthusiasm for science and communicate the importance of scientific advancement like was done for [the response to] Sputnik.” —Dr. Susan Hockfield “We have an opportunity to really communicate and explain in a better way, what scientific data really mean and what is the respective context. There is no absolute truth...
Dear Research Advocate, Anticipation is building for the Research!America 2020 Virtual #RAForum: Straight Talk: Securing a Science-Strong Future , featuring federal officials, members of Congress from both sides of the aisle, and other leaders from across the R&D and public health ecosystem to explore the intersection of public and private sector-driven science and pandemic response, recovery, and preparedness. An important late-breaking addition to the Forum program is HHS Secretary Alex M. Azar II, who will be in conversation with journalist and Research!America board member Susan Dentzer. We are also excited to let you know ADM Brett P. Giroir, MD, the Assistant Secretary for Health...
Dear Research Advocate, On (but mostly off) Capitol Hill : Neither the House nor Senate is expected to reconvene until after Labor Day. As things stand, it may be late September before a final COVID-19 emergency spending package takes shape. The longer the delay on that front, the greater the chances that a continuing resolution (CR) will be attached, flat-funding the government until after (potentially long after) the November elections. Sound the Alarm : If this no-action update sounds all-too-familiar, that’s because it is. The push and pull of differing funding priorities and election-year politics are fogging the lens such that the most important consideration – the crying need for...
Dear Research Advocate, On Capitol Hill : Senate Republicans have a new legislative proposal for COVID-19 emergency supplemental spending which includes provisions such as extended unemployment benefits and emergency funding for USPS, but no supplemental funding to restore COVID-19-eroded research dollars. Speaking up now is essential if there is to be an emergency spending bill that fully fights back COVID-19’s attack on the nation’s economy and health security. Reach out to your members of Congress to encourage them to include at least $26 billion in funding to restart lifesaving research supported by our health and science agencies. Here are two ways you can act right away: send this...
The pandemic continues to reconfigure our society and our individual lives. Our R&D ecosystem is simultaneously at the center of the COVID-19 response and placed at risk by it. What is certain during this profoundly uncertain period in our nation’s history is this: inaction breeds tragedy. Inaction on Capitol Hill : Negotiations over desperately needed emergency spending legislation and FY21 appropriations are in a holding pattern. In a troubling sign, reports today surfaced that federal agencies have been told to prepare for flat funding via a CR through December. Let’s face it: federal leaders are waiting to see who blinks first, even as desperation mounts and priorities like medical...
Dear Research Advocate, Let’s cut to the chase : There is so much at stake right now as Congressional leadership and the Administration negotiate the next COVID-19 supplemental, timing included. It’s a ‘now’ situation for Americans and those who represent them; it’s a ‘now’ situation for advocates, too. Research!America sent a letter to Congressional leadership urging them to include at least $26 billion in supplemental research funding in the legislation. Now is the time to meet the moment — don’t let disappointment or fatigue set in — your advocacy has worked in the past and it can work again! Reach out now and encourage your Members of Congress to weigh in with negotiators to achieve a...
Dear Research Advocate, Phase 3 enrollment is now underway for a number of COVID-19 vaccine clinical trials. That science has moved so quickly from first identification of the virus to Phase 3 trials, speaks to remarkable public-private sector collaboration. It also speaks to the absolute necessity of taxpayer investment in basic, discovery science over many years; a lesson we must not ignore as we plan responses to the pandemics that will surely follow. To help move the massive trial enrollment process along, NIH has launched the COVID-19 Prevention Trials Network (COVPN), merging networks already funded by NIAID for HIV and other infectious disease trials. Each of the Phase 3 clinical...

Pages

Sidebar Quote

You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter